share_log

GlycoMimetics Shares Are Trading Higher After the Company Announced It Will Merge With Crescent Biopharma and Secured $200 in Funding to Advance Its Oncology Pipeline.

GlycoMimetics Shares Are Trading Higher After the Company Announced It Will Merge With Crescent Biopharma and Secured $200 in Funding to Advance Its Oncology Pipeline.

GlycoMimetics股票交易上漲,因爲公司宣佈將與Crescent Biopharma合併,並獲得2億美元的資金來推進其腫瘤學研究項目。
Benzinga ·  2024/10/29 08:18

GlycoMimetics股票交易上漲,因爲公司宣佈將與Crescent Biopharma合併,並獲得2億美元的資金來推進其腫瘤學研究項目。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論